NEW YORK (GenomeWeb News) — Lipomics Technologies and the University of California, San Diego, plan to investigate the underlying mechanisms involved in insulin-resistance disorders.
 
Under the agreement, Lipomics and UCSD will collaborate on basic and clinical research projects to study non-insulin-dependent diabetes mellitus, obesity, and other insulin-resistance disorders, as well as studies that aim to identify the roles different organ systems play in NIDDM, the company said today.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.